摘要:
Objective Observing the efficacy and safety of valproate and topiramate in preventing migraine of children.Methods Children with migraine were randomly divided into two groups who were diagnosed and treated in our hospital form May 2013 to March 2016.The group of topiramate had 47 cases,the initial daily dose was 0.5mg/kg,the dose increaseed 1 mg/kg per week,the maximum dose was 2.5mg/kg.The group of valproate had 48 cases,the initial daily dose was 0.4g,we adjusted the dose according to the condition and adverse reactions of children,the maximum dose was 1.2g.We compared the efficacy and adverse reactions of two groups.Results The effective rate of topiramat group was 85.1%.The effective rate of valproate group was 87.2%.The effective rate of two groups had no significant difference.A small amount of valproate group appeared diarrhea,vomiting and other gastrointestinal symptoms.A small amount of topiramate group appeared drowsiness,dizziness and other symptoms of central nervous system.Conclusion The valproate and topiramate could be effective in preventing migraine in children,The adverse reactions could be tolerated.We could choose different drugs according to the specific circumstances of children.%目的 对比分析妥泰和丙戊酸镁预防治疗小儿偏头痛的有效性和安全性.方法 选取2013年5月到2016年3月在我院诊断并接受治疗的偏头痛患儿95例,按入院先后顺序随机分为两组,妥泰组47例,起始量为每天0.5mg/kg,每周递增1mg/kg,最大量每天2.5mg/kg,早晚分服;丙戊酸镁组48例,起始剂量每天0.4g,根据病情及药物不良反应调整剂量,最高剂量不高于每天1.2g,早晚分服.观察两组的疗效和不良反应.结果 经治疗后,丙戊酸镁组治愈15例,显效20例,有效6例,总有效率为87.2%;妥泰组治愈17例,显效14例,有效9例,总有效率为85.1%.两组总有效率无明显差异(P>0.05).丙戊酸镁组的少量患儿出现腹泻、呕吐等胃肠道症状;妥泰组的少量患儿出现嗜睡、头晕等中枢神经系统症状.不良反应均可耐受,不影响患儿的治疗.结论 妥泰和丙戊酸镁均可有效预防治疗偏头痛患儿,两者疗效无明显差异,不良反应均可耐受,临床可根据患儿具体情况选择用药.